Who owns SUMMIT THERAPEUTICS INC CLL OPT 10/26 14.0 CAL?

Tip: Access positions for across all investors

Analyze quarterly positions in Summit Therapeutics Inc Cll Opt 10/26 14.0 Cal with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Summit Therapeutics Inc Cll Opt 10/26 14.0 Cal stock

Who bought or sold SUMMIT THERAPEUTICS INC CLL OPT 10/26 14.0 CAL this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
EverSource Wealth Advisors 500.00 $7.3k 100% Jun 2026
 View chart